SearchThe purpose of this research study is to test if a reduction in depressive symptoms in response to treatment with an antidepressant improves levels of certain proteins which have been associated with increased risk for the development of Alzheimer’s disease (AD).
Study Length
Approximately 2 months for screening and 8 weeks for treatment.Disorder/Condition
DepressionInclusion Criteria
You may be eligible for our study if you:
- Are 60 or older
- Are diagnosed with depression or have symptoms of depression
- Feel comfortable completing an MRI
- Are willing to be treated with Escitalopram (Lexapro) a widely prescribed antidepressant
- Are willing to have a lumbar puncture procedure
Study Title (brief)
The ABD StudyStudy Description (brief)
The purpose of this research study is to test if a reduction in depressive symptoms in response to treatment with an antidepressant improves levels of certain proteins which have been associated with increased risk for the development of Alzheimer’s disease (AD).
Study Contact
For questions and concerns regarding any of this information, contact Dr. Antero Sarreal, Study Coordinator, 845-398-6532 or asarreal@nki.rfmh.org